Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Enanta Pharmaceuticals Inc (NASDAQ:ENTA)

During the Trading Day
37.56 +0.40 / +1.08%
As of 3:59pm ET
Day’s Change
During After-Hours   Switch to standard view »
37.57 +0.0075 / +0.02%
Volume: 7.0K

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year




Operating ActivitiesNet Income / Starting Line1.6M1.4M9.6M34.4M
Total Other Cash Flow24.4M21.0M64.0K-12.4M
Funds From Operations26.4M22.5M9.9M22.4M
Funds From/For Other Operating Expenses2.4M-93.0K-741.0K2.3M
Net Cash Flow - Operating Activities24.0M22.6M10.7M20.2M
InvestingIncrease In Investments-33.6M-47.7M-115.9M-98.4M
Decrease In Investments16.8M28.7M47.3M99.9M
Capital Expenditures-445.0K-252.0K-606.0K-1.0M
Fixed Asset Disposal9.0K66.0K0.003.0K
Other Investing - Uses-436.0K0.000.000.00
Other Investing - Sources0.001.1M0.000.00
Net Cash Flow Investing-17.7M-18.0M-69.2M497.0K
FinancingShort Term Borrowings0.
Long Term Borrowings0.
Long Term Debt Reduction0.
Net Proceeds Stock Sale34.0K141.0K56.9M1.1M
Common Preferred Redeemed0.00-1.1M0.000.00
Common Dividends0.
Cash Dividends Paid - Total0.
Other Sources - Financing0.000.000.00110.0K
Other Uses - Financing0.
Net Cash Flow - Financing34.0K-909.0K56.9M1.2M
Exchange RateEffect of Exchange Rate on Cash----0.000.00--
Net Change In Cash6.4M3.7M-1.7M21.8M